Skip to main content
Loading...
Menu social network
LinkedIn
Facebook
X
Youtube
Menu top
Assistance
User account menu
Log in
Main navigation
Home
Programme
Download the app
App
Download the app
App
Menu
Login
Close
Main navigation mobile
Home
Programme
Menu top
Assistance
Menu social network
LinkedIn
Facebook
X
Youtube
230 results
D1.362 - Exploratory Efficacy, Pharmacokinetics, Pharmacodynamics and Safety of YH35324, a Long-Acting high-affinity IgETrap-Fc protein, in Patients with Chronic Spontaneous Urticaria Refractory to Omalizumab
D1.363 - Efficacy and safety of Mepolizumab in treatment of eosinophilic granulomatosis with polyangiitis
D1.364 - Update on the Observed incidence of Anaphylaxis and Serum Sickness in Patients Receiving Omalizumab in a Canadian Tertiary Allergy/Asthma Clinic
D1.365 - ZL-1503: A Bispecific Antibody Targeting Inflammatory and Pruritogenic Pathways with a Prolonged Serum Half-life and Sustained Activity in Non-human Primates
D1.390 - Long-term safety and efficacy of navenibart in participants with hereditary angioedema (HAE): Initial combined results from ALPHA-STAR and ALPHA-SOLAR
D1.366 - Improvement Over Time in Specific Aspects of Quality of Life in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab
D1.367 - Dupilumab for refractory pruritus in hematological and non-hematological malignancies – preliminary results
D1.368 - Anti-interleukin-5 treatment in patients with severe eosinophilic asthma provides consistent symptom control for at least 8 years
D1.369 - Characteristics of patients with severe asthma undergoing biological treatment at a reference center
D1.371 - Dupilumab for the treatment of refractory severe chronic spontaneous urticaria
000098 - A peri-Anesthetic Reaction in a Pediatric Patient with Anaplastic Astrocytoma of the Body's Corpus Callosum
000111 - Allergy to Isobornyl Acrylate (IBOA) present in Sensors and Insulin Infusion Systems in Pediatric Population
000565 - Omalizumab for oral desensitization in children with cow's milk allergy
000762 - Transition: the future starts earlier
001537 - Effectiveness of a Provincial Policy to Improve Epinephrine Use for Anaphylaxis in Schools in Alberta, Canada: A Pre-Post Study
001566 - Anaphylaxis to diethyltoluamide (DEET) containing insect repellent
001643 - Clinical-laboratory evaluation of children with chronic urticaria
100147 - Flare up by diethylthiurea/dibutylthiourea
100536 - Late onset immunodeficiency in children
100629 - Asthma outcomes in young adults completed sublingual immunotherapy in adolescence
Pagination
First page
First
Previous page
Previous
Page
1
Page
2
Page
3
Page
4
Current page
5
Page
6
Page
7
Page
8
Page
9
…
Next page
Next
Last page
Last
Download the app
The congress at your fingertips
Available on
Download